139 related articles for article (PubMed ID: 29449695)
1. Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression.
Lin J; Ma JC; Yang J; Yin JY; Chen XX; Guo H; Wen XM; Zhang TJ; Qian W; Qian J; Deng ZQ
Oncogene; 2018 May; 37(18):2432-2443. PubMed ID: 29449695
[TBL] [Abstract][Full Text] [Related]
2. Establishment and molecular characterization of decitabine-resistant K562 cells.
Wen XM; Zhang TJ; Ma JC; Zhou JD; Xu ZJ; Zhu XW; Yuan Q; Ji RB; Chen Q; Deng ZQ; Lin J; Qian J
J Cell Mol Med; 2019 May; 23(5):3317-3324. PubMed ID: 30793488
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
[TBL] [Abstract][Full Text] [Related]
4. The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia.
Chen Q; Lin J; Qian J; Deng ZQ; Qian W; Yang J; Li Y; Chen XX; Ma YJ; Ma JC; Liu Q
Genet Test Mol Biomarkers; 2013 Jun; 17(6):508-11. PubMed ID: 23495895
[TBL] [Abstract][Full Text] [Related]
5. MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.
Liu YX; Wang L; Liu WJ; Zhang HT; Xue JH; Zhang ZW; Gao CJ
J Hematol Oncol; 2016 Aug; 9(1):69. PubMed ID: 27516205
[TBL] [Abstract][Full Text] [Related]
6. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.
Xu C; Fu H; Gao L; Wang L; Wang W; Li J; Li Y; Dou L; Gao X; Luo X; Jing Y; Chim CS; Zheng X; Yu L
Oncogene; 2014 Jan; 33(1):44-54. PubMed ID: 23208504
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia.
Lu Y; Li Y; Chai X; Kang Q; Zhao P; Xiong J; Wang J
Gene; 2017 Apr; 607():41-46. PubMed ID: 28069548
[TBL] [Abstract][Full Text] [Related]
10. Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
Cancer Lett; 2015 May; 360(2):245-56. PubMed ID: 25697481
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.
Taverna S; Giallombardo M; Pucci M; Flugy A; Manno M; Raccosta S; Rolfo C; De Leo G; Alessandro R
Oncotarget; 2015 Sep; 6(26):21918-33. PubMed ID: 26116834
[TBL] [Abstract][Full Text] [Related]
12. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
13. lncRNA UCA1 Contributes to Imatinib Resistance by Acting as a ceRNA Against miR-16 in Chronic Myeloid Leukemia Cells.
Xiao Y; Jiao C; Lin Y; Chen M; Zhang J; Wang J; Zhang Z
DNA Cell Biol; 2017 Jan; 36(1):18-25. PubMed ID: 27854515
[TBL] [Abstract][Full Text] [Related]
14. RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.
Gu C; Feng M; Yin Z; Luo X; Yang J; Li Y; Li T; Wang R; Fei J
Oncotarget; 2016 Apr; 7(15):20561-73. PubMed ID: 26967392
[TBL] [Abstract][Full Text] [Related]
15. High expression of long non-coding RNA H19 is required for efficient tumorigenesis induced by Bcr-Abl oncogene.
Guo G; Kang Q; Chen Q; Chen Z; Wang J; Tan L; Chen JL
FEBS Lett; 2014 May; 588(9):1780-6. PubMed ID: 24685695
[TBL] [Abstract][Full Text] [Related]
16. MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells.
Ma J; Wu D; Yi J; Yi Y; Zhu X; Qiu H; Kong R; Lin J; Qian J; Deng Z
Biomed Pharmacother; 2019 Apr; 112():108623. PubMed ID: 30797151
[TBL] [Abstract][Full Text] [Related]
17. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA H19/miR-675 Axis Promotes Gastric Cancer via FADD/Caspase 8/Caspase 3 Signaling Pathway.
Yan J; Zhang Y; She Q; Li X; Peng L; Wang X; Liu S; Shen X; Zhang W; Dong Y; Lu J; Zhang G
Cell Physiol Biochem; 2017; 42(6):2364-2376. PubMed ID: 28848149
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells.
Lin TY; Chen KC; Liu HJ; Liu AJ; Wang KL; Shih CM
PLoS One; 2016; 11(5):e0156260. PubMed ID: 27228340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
